Yıl: 2019 Cilt: 49 Sayı: 6 Sayfa Aralığı: 1647 - 1654 Metin Dili: İngilizce DOI: 10.3906/sag-1901-128 İndeks Tarihi: 15-05-2020

Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome

Öz:
Background/aim: Autoimmune diseases are a remarkable issue for researchers due to their adverse effects on the auditory system, butfor primary Sjögren’s syndrome (pSS) there is little research on the comprehensive audiological findings in literature. The main objectiveof this study was to investigate the medial olivocochlear efferent functions of subjects with pSS and to examine the audiological findings.Materials and methods: The study included 36 subjects with pSS and 36 healthy subjects. All the subjects underwent testing includingpure tone, speech, and high frequency audiometry; tympanometry and acoustic reflexes; distortion product otoacoustic emissions(DPOAE); and suppression of DPOAE.Results: The hearing thresholds of the pSS group were higher than those of the control at all frequencies (P < 0.001). Minimal tomild sensorineural hearing loss was observed in 52.77% of all the subjects with pSS. Additionally, all of the subjects had type A curvetympanograms, but the static compliances of the pSS group were lower and the acoustic reflex thresholds were higher than in the control(P < 0.001). In suppression levels of DPOAE, no statistically significant difference was found between the groups (P > 0.05).Conclusion: The study indicates that because of obtaining normal suppression levels in DPOAE, the medial olivocochlear efferentsystem is functional in pSS. However, there is a need for more tests, including auditory brainstem response, to evaluate the afferentauditory system in pSS.
Anahtar Kelime:

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ferro F, Vagelli R, Bruni C, Cafaro G, Marcucci E et al. One year in review 2016: Sjögren’s syndrome. Clinical Experimental Rheumatology 2016; 34 (2): 161-171.
  • 2. Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of primary Sjögren’s syndrome in a US population‐based cohort. Arthritis Care and Research 2017; 69 (10): 1612-1616. doi: 10.1002/acr.23173
  • 3. Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clinical Epidemiology 2014; 30 (6): 247-255. doi: 10.2147/CLEP. S47399
  • 4. Birlik M, Akar S, Gurler O, Sari I, Birlik B et al. Prevalence of primary Sjogren’s syndrome in Turkey: a population‐based epidemiological study. International Journal of Clinical Practice 2009; 63 (6): 954-961. doi:10.1111/j.1742-1241.2008.01749.x
  • 5. Eckhard A, Gleiser C, Arnold H, Rask-Andersen H, Kumagami H et al. Water channel proteins in the inner ear and their link to hearing impairment and deafness. Molecular Aspects of Medicine 2012; 33 (5-6): 612-637. doi:10.1016/j.mam.2012.06.004
  • 6. González JLT, Torres JR, Ríos YH, González MJV, MendezSaenz MA et al. Extended high-frequency audiometry as early detection of hearing loss in primary Sjögren syndrome. Clinical Rheumatology 2017; 36 (10): 2237-2241. doi: 10.1007/s10067- 017-3750-2
  • 7. Thanooja CV, Augustine AM, Lepcha A, Sandhya P, Tyagi AK et al. Audiological profile in primary Sjögren’s syndrome in a tertiary care setting and its clinical implications. Indian Journal of Otolaryngology Head and Neck Surgery 2018; 70 (1): 59-65. doi:10.1007/s12070-015-0956-y
  • 8. Thanooja CV, Augustine AM, Lepcha A, Sandhya P, Tyagi AK et al. Early hearing loss detection in rheumatoid arthritis and primary Sjögren syndrome using extended high frequency audiometry. Clinical Rheumatology 2018; 37 (2): 367-373. doi:10.1007/s10067-017-3959-0
  • 9. Oztürk A, Yalçin Ş, Kaygusuz I, Sahin S, Gök U et al. Highfrequency hearing loss and middle ear involvement in rheumatoid arthritis. American Journal of Otolaryngology 2004; 25 (6): 411-417. doi: 10.1016/j.amjoto.2004.06.001
  • 10. Kemp DT. Otoacoustic emissions, their origin in cochlear function, and use. British Medical Bulletin 2002; 63: 223-241.
  • 11. Maison S, Micheyl C, Collet L. The medial olivocochlear efferent system in humans: structure and function. Scandinavian Audiology Supplementum 1999; 51: 77-84.
  • 12. Hatzopoulos S, Amoroso C, Aimoni C, Monaco AL, Govoni M et al. hearing loss evaluation of Sjogren’s Syndrome using distortion product otoacoustic emissions. Acta Oto-Laryngologica 2002; 548: 20-25. doi: 10.1080/00016480260094929
  • 13. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data‐driven methodology involving three international patient cohorts. Arthritis Rheumatology 2017; 69 (1): 35-45. doi: 10.1002/ art.39859
  • 14. Clark JG. Uses and abuses of hearing loss classification. ASHA 1981; 23 (7): 493-500.
  • 15. Riga M, Komis A, Maragkoudakis P, Korres G, Danielides V. Objective assessment of subjective tinnitus through contralateral suppression of otoacoustic emissions by white noise; suggested cut-off points. International Journal of Audiology 2016; 55 (12): 775-781. doi: 10.1080/14992027.2016.1219778
  • 16. Riga M, Komis A, Maragoudakis P, Korres G, Ferekidis E et al. Objective assessment of subjective tinnitus through contralateral suppression of otoacoustic emissions by white noise: effects of frequency, gender, tinnitus bilaterality and age. Acta Otorhinolaryngologica Italy 2018; 38 (2): 131-137. doi: 10.14639/0392-100X-1465
  • 17. Kumar P, Grover V, Sanju HK, Sinha S. Assessment of rock musician’s efferent system functioning using contralateral suppression of otoacoustic emissions. World Journal of Otorhinolaryngology-Head and Neck Surgery 2016; 2 (4): 214- 218. doi: 10.1016/j.wjorl.2016.11.006
  • 18. Oppitz SJ, Silva LCL, Garcia MV, Silveira AFD. High-frequency auditory thresholds in normal hearing adults. CoDAS 2018; 30 (4): e20170165. doi: 10.1590/2317-1782/20182017165
  • 19. Giraud AL, Collet L, Chéry-Croze S, Magnan J, Chays A. Evidence of a medial olivocochlear involvement in contralateral suppression of otoacoustic emissions in humans. Brain Research 1995; 705 (1-2): 15-23. doi: 10.1016/0006- 8993(95)01091-2
  • 20. Doig JA, Whaley K, Dick WC, Nuki G, Williamson J et al. Otolaryngological aspects of Sjögren’s syndrome. British Medical Journal 1971; 4 (5785): 460-463. doi: 10.1136/ bmj.4.5785.460
  • 21. Hatzopoulos S, Amoroso C, Aimoni C, Monaco AL, Govoni M et al. Hearing loss evaluation of sjogren’s syndrome using distortion product otoacoustic emissions. Acta Otolaryngologica 2002; 548: 20-25. doi: 10.1080/00016480260094929
  • 22. Almeida RS, Oliveira AA, Pego PM, Abuowda Y, Gaspar I et al. Sensorineural hearing loss as the first manifestation of Sjögren’s syndrome. Revista da Associação Médica Brasileira 2017; 63 (1): 7-9. doi: 10.1590/1806-9282.63.01.7
  • 23. Chai J, Logigian EL. Neurological manifestations of primary Sjogren’s syndrome. Current Opinion in Neurology 2010; 23 (5): 509-513. doi: 10.1097/WCO.0b013e32833de6ab
  • 24. Jourde-Chiche N, Mancini J, Dagher N, Taugourdeau S, Thomas G et al. Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French Pharmacovigilance Network. Annals of the Rheumatic Diseases 2012; 71 (9): 1586. doi: 10.1136/annrheumdis-2011-201265
APA Gunduz B, YILDIRIM GÖKAY N, Güven S, ORHAN E, KARAMERT R, günendi z (2019). Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. , 1647 - 1654. 10.3906/sag-1901-128
Chicago Gunduz Bulent,YILDIRIM GÖKAY NURİYE,Güven Serdar Can,ORHAN Emre,KARAMERT RECEP,günendi zafer Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. (2019): 1647 - 1654. 10.3906/sag-1901-128
MLA Gunduz Bulent,YILDIRIM GÖKAY NURİYE,Güven Serdar Can,ORHAN Emre,KARAMERT RECEP,günendi zafer Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. , 2019, ss.1647 - 1654. 10.3906/sag-1901-128
AMA Gunduz B,YILDIRIM GÖKAY N,Güven S,ORHAN E,KARAMERT R,günendi z Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. . 2019; 1647 - 1654. 10.3906/sag-1901-128
Vancouver Gunduz B,YILDIRIM GÖKAY N,Güven S,ORHAN E,KARAMERT R,günendi z Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. . 2019; 1647 - 1654. 10.3906/sag-1901-128
IEEE Gunduz B,YILDIRIM GÖKAY N,Güven S,ORHAN E,KARAMERT R,günendi z "Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome." , ss.1647 - 1654, 2019. 10.3906/sag-1901-128
ISNAD Gunduz, Bulent vd. "Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome". (2019), 1647-1654. https://doi.org/10.3906/sag-1901-128
APA Gunduz B, YILDIRIM GÖKAY N, Güven S, ORHAN E, KARAMERT R, günendi z (2019). Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. Turkish Journal of Medical Sciences, 49(6), 1647 - 1654. 10.3906/sag-1901-128
Chicago Gunduz Bulent,YILDIRIM GÖKAY NURİYE,Güven Serdar Can,ORHAN Emre,KARAMERT RECEP,günendi zafer Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. Turkish Journal of Medical Sciences 49, no.6 (2019): 1647 - 1654. 10.3906/sag-1901-128
MLA Gunduz Bulent,YILDIRIM GÖKAY NURİYE,Güven Serdar Can,ORHAN Emre,KARAMERT RECEP,günendi zafer Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. Turkish Journal of Medical Sciences, vol.49, no.6, 2019, ss.1647 - 1654. 10.3906/sag-1901-128
AMA Gunduz B,YILDIRIM GÖKAY N,Güven S,ORHAN E,KARAMERT R,günendi z Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. Turkish Journal of Medical Sciences. 2019; 49(6): 1647 - 1654. 10.3906/sag-1901-128
Vancouver Gunduz B,YILDIRIM GÖKAY N,Güven S,ORHAN E,KARAMERT R,günendi z Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. Turkish Journal of Medical Sciences. 2019; 49(6): 1647 - 1654. 10.3906/sag-1901-128
IEEE Gunduz B,YILDIRIM GÖKAY N,Güven S,ORHAN E,KARAMERT R,günendi z "Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome." Turkish Journal of Medical Sciences, 49, ss.1647 - 1654, 2019. 10.3906/sag-1901-128
ISNAD Gunduz, Bulent vd. "Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome". Turkish Journal of Medical Sciences 49/6 (2019), 1647-1654. https://doi.org/10.3906/sag-1901-128